Moderna news, latest stories & analysis
Find today's trending Moderna news & headlines
Moderna stock takes a 20% hit: here’s why
- Moderna lowers its full-year sales guidance by up to $1.0 billion.
- The biotech firm cited 4 reasons for the revised 2025 outlook.
- Moderna stock is now down close to 30% versus its YTD high.
January 13, 2025
What made Moderna stock pop 10% on Tuesday?
April 9, 2024
Three top U.S. biotech stocks to buy in April
March 28, 2024
Trending news
13th January
Moderna stock takes a 20% hit: here’s why
14th December
Moderna stock popped 15% on Thursday: explore why